ARTICLE | Distillery Therapeutics
Endocrine / Metabolic
July 25, 2017 8:33 PM UTC
In vitro and mouse studies suggest a modified NMU peptide that agonizes NMUR2 could help treat obesity. The agonist consisted of a PEGylated, eight amino acid from the NMU C-terminus containing a napt...
BCIQ Company Profiles
BCIQ Target Profiles